Roivant Sciences (ROIV) CFO RSU vesting leads to 18,962 shares withheld

Rhea-AI Filing Summary

Roivant Sciences Ltd. CFO Richard Pulik reported a tax-withholding share disposition related to restricted stock units (RSUs). On this event, 18,962 common shares were withheld at a value of $32.41 per share to cover tax obligations triggered by the vesting and settlement of previously granted RSUs. After this non‑market transaction, Pulik directly holds 278,549 common shares, indicating he retains a substantial equity position in the company.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Pulik Richard

Role CFO

Type	Security	Shares	Price	Value
Tax Withholding	Common Shares	18,962	$32.41	$615K

Holdings After Transaction: Common Shares — 278,549 shares (Direct, null)

Footnotes (1)

1. [object Object]

Key Figures

Shares withheld for taxes: 18,962 shares Withholding share value: $32.41 per share Shares held after transaction: 278,549 shares

3 metrics

Shares withheld for taxes 18,962 shares Tax-withholding disposition tied to RSU vesting

Withholding share value $32.41 per share Value used for RSU tax-withholding settlement

Shares held after transaction 278,549 shares Direct holdings of CFO Richard Pulik after RSU tax withholding

Key Terms

RSUs, net settlement, tax withholding obligations, vesting and settlement

4 terms

RSUs financial

"Represents the "net settlement" by the Issuer of RSUs previously granted"

RSUs, or restricted stock units, are a form of company shares given to employees as part of their compensation. They are typically awarded with certain restrictions, such as a waiting period before they can be fully owned or sold, similar to earning a gift that becomes fully yours over time. For investors, RSUs can impact a company's stock offerings and reflect how much the company relies on stock-based incentives to attract and retain talent.

net settlement financial

"Represents the "net settlement" by the Issuer of RSUs previously granted"

tax withholding obligations financial

"in order to satisfy applicable tax withholding obligations in connection with the vesting"

vesting and settlement financial

"in connection with the vesting and settlement of such RSUs"

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Pulik Richard

(Last) (First) (Middle)

C/O ROIVANT SCIENCES LTD.

7TH FLOOR, 50 BROADWAY

(Street)

LONDON SW1H 0DB

(City) (State) (Zip)

UNITED KINGDOM

(Country)

2. Issuer Name and Ticker or Trading Symbol
Roivant Sciences Ltd. [ ROIV ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	CFO

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/20/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Shares	05/20/2026		F		18,962(1)	D	$32.41	278,549	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents the "net settlement" by the Issuer of RSUs previously granted to the reporting person in order to satisfy applicable tax withholding obligations in connection with the vesting and settlement of such RSUs.

Remarks:

	By: /s/ Jo Chen, as Attorney-in-Fact for Richard Pulik	05/22/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What did Roivant Sciences (ROIV) CFO Richard Pulik report in this Form 4?

Roivant Sciences CFO Richard Pulik reported a tax-related share disposition. 18,962 common shares were withheld to satisfy tax obligations on vested RSUs, a non-market transaction. Following this, he directly holds 278,549 common shares in the company.

Was the Roivant Sciences (ROIV) CFO’s Form 4 transaction an open-market sale?

No, the Form 4 shows a tax-withholding disposition, not an open-market sale. Shares were withheld by Roivant Sciences to cover tax obligations arising from vesting and settlement of previously granted RSUs to CFO Richard Pulik.

How many Roivant Sciences (ROIV) shares were withheld for taxes from the CFO’s RSUs?

The filing reports that 18,962 Roivant Sciences common shares were withheld. These shares were used to satisfy applicable tax withholding obligations linked to the vesting and settlement of RSUs granted to CFO Richard Pulik.

What is Roivant Sciences (ROIV) CFO Richard Pulik’s direct shareholding after this Form 4 event?

After the tax-withholding disposition, Richard Pulik directly holds 278,549 Roivant Sciences common shares. This figure reflects his remaining equity position following the net settlement of RSUs used to cover associated tax obligations.

What does the footnote about RSU ‘net settlement’ mean in Roivant Sciences (ROIV) Form 4?

The footnote explains the issuer used a “net settlement” of previously granted RSUs. Roivant Sciences withheld shares from the RSU vesting to pay required taxes, instead of requiring separate cash payment from CFO Richard Pulik.